No Data
No Data
Is Gossamer Bio (NASDAQ:GOSS) Weighed On By Its Debt Load?
Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress
Gossamer Bio And 2 Other Promising Penny Stocks On US Exchanges
Gossamer Bio's Strategic Focus on PAH Unmet Needs and Seralutinib Efficacy Drives Buy Rating
12 Health Care Stocks Moving In Thursday's Pre-Market Session
After Plunging -15.92% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS)
loading...
George Soros II : LFG![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)